BIOSIS HEALING introductory

Beijing Biosis Healing Biological Technology Co.,Ltd is committed to providing advanced and comprehensive solutions for surgery and repair, and promoting surgical clinical innovation. Provided innovative technology products such as regenerative medical bio-materials, implantable soft tissue repair patch, and intelligent minimally invasive surgical instruments with independent intellectual property rights.

The self-developed non-crosslinked Extracellular Matrix biomaterial (SIS material) project was included in the key project of the National 863th New Material Field of the Ministry of Science and Technology and the transformation of the original technological achievements and industrialization projects of Zhongguancun. We havegot77national invention patents and 14 international patents, and the core technologies are patented in the US, UK and Germany. Based on the core technology, a series of implantable SIS material for tissue repair have been developed, covering a number of important surgical fields such as gastrointestinal surgery, abdominal wall surgery, anorectal surgery, thoracic surgery, neurosurgery, orthopedics, and maxillofacial surgery. This functional regenerative products provide a comprehensive solution. A number of products are included in the special approval and priority approval procedures for innovative medical devices of the State Drug Administration.

Beijing Biosis Healing Biological Technology Co.,Ltd is committed to providing advanced and comprehensive solutions for surgery and repair, and promoting surgical clinical innovation. Provided innovative technology products such as regenerative medical bio-materials, implantable soft tissue repair patch, and intelligent minimally invasive surgical instruments with independent intellectual property rights. The self-developed non-crosslinked Extracellular Matrix biomaterial (SIS material) project was included in the key project of the National 863th New Material Field of the Ministry of
Science and Technology and the transformation of the original technological achievements and industrialization projects of Zhongguancun. We havegot77national invention patents and 14 international patents, and the core technologies are patented in the US, UK and Germany. Based on the core technology, a series of implantable SIS material for tissue repair have been developed, covering a number of
important surgical fields such as gastrointestinal surgery, abdominal wall surgery, anorectal surgery, thoracic surgery, neurosurgery, orthopedics, and maxillofacial surgery. This functional regenerative products provide a comprehensive solution. A number of products are included in the special approval and priority approval procedures for innovative medical devices of the State Drug Administration.

Development history

友情链接:

百度一下   |   京东   |  

版权所有 北京博辉瑞进生物科技有限公司 京ICP备16026579号 (京)-非经营性-2017-0030